These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3528055)

  • 1. Survival results from a phase III study of simultaneous versus 1-hour sequential methotrexate-5-fluorouracil chemotherapy in head and neck cancer.
    Browman GP; Levine MN; Russell R; Young JE; Archibald SD
    Head Neck Surg; 1986; 8(3):146-52. PubMed ID: 3528055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective randomized trial of one-hour sequential versus simultaneous methotrexate plus 5-fluorouracil in advanced and recurrent squamous cell head and neck cancer.
    Browman GP; Archibald SD; Young JE; Hryniuk WM; Russell R; Kiehl K; Levine MN
    J Clin Oncol; 1983 Dec; 1(12):787-92. PubMed ID: 6366132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methotrexate/fluorouracil scheduling influences normal tissue toxicity but not antitumor effects in patients with squamous cell head and neck cancer: results from a randomized trial.
    Browman GP; Levine MN; Goodyear MD; Russell R; Archibald SD; Jackson BS; Young JE; Basrur V; Johanson C
    J Clin Oncol; 1988 Jun; 6(6):963-8. PubMed ID: 3286831
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomized comparison of cisplatin plus fluorouracil and carboplatin plus fluorouracil versus methotrexate in advanced squamous-cell carcinoma of the head and neck: a Southwest Oncology Group study.
    Forastiere AA; Metch B; Schuller DE; Ensley JF; Hutchins LF; Triozzi P; Kish JA; McClure S; VonFeldt E; Williamson SK
    J Clin Oncol; 1992 Aug; 10(8):1245-51. PubMed ID: 1634913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Gefitinib, Methotrexate and Methotrexate plus 5-Fluorouracil as palliative treatment in recurrent head and neck squamous cell carcinoma.
    Kushwaha VS; Gupta S; Husain N; Khan H; Negi MP; Jamal N; Ghatak A
    Cancer Biol Ther; 2015; 16(2):346-51. PubMed ID: 25756517
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A phase II trial of cisplatin, methotrexate, levofolinic acid, and 5-fluorouracil in the treatment of patients with locally advanced, metastatic squamous cell carcinoma of the head and neck.
    Caponigro F; Comella P; Marcolin P; Russo Spena F; Biglietto M; Cartenì G; De Lucia L; Avallone A; Gravina A; Comella G
    Cancer; 1999 Feb; 85(4):952-9. PubMed ID: 10091775
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternating combination chemotherapy using cisplatin-bleomycin with sequential methotrexate-5-FU plus leucovorin rescue in patients with head and neck cancer.
    Panasci L; Gravenor D; Black M; Frenkiel S; Margolese R
    Cancer Treat Rep; 1985 Sep; 69(9):1015-7. PubMed ID: 2411401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combination therapy with methotrexate and 5-fluorouracil: a prospective randomized clinical trial of order of administration.
    Coates AS; Tattersall MH; Swanson C; Hedley D; Fox RM; Raghavan D
    J Clin Oncol; 1984 Jul; 2(7):756-61. PubMed ID: 6376719
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Chemotherapy with MTX, 5-FU and CDGP for treatment of newly diagnosed head and neck cancer].
    Sakoda T; Morizane R; Nakahara K; Enomoto Y; Nosaka A; Enomoto T; Kitano H
    Gan To Kagaku Ryoho; 2009 Sep; 36(9):1451-5. PubMed ID: 19755812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Promising long-term results with attenuated adverse effects by methotrexate-containing sequential chemoradiation therapy in locally advanced head and neck squamous cell carcinoma.
    Tsai TL; Chu PY; Tai SK; Wang YF; Yang MH; Wang LW; Lirng JF; Chang SY
    Jpn J Clin Oncol; 2011 Oct; 41(10):1182-93. PubMed ID: 21862506
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Importance of primary site in assessing chemotherapy response and 7-year survival data in advanced squamous-cell carcinomas of the head and neck treated with initial combination chemotherapy without cisplatin.
    Hill BT; Price LA; MacRae K
    J Clin Oncol; 1986 Sep; 4(9):1340-7. PubMed ID: 3746375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chemotherapy of advanced head and neck cancer: updated results of a randomized trial of the order of administration of sequential methotrexate and 5-fluorouracil.
    Mackintosh JF; Coates AS; Tattersall MH; Swanson C
    Med Pediatr Oncol; 1988; 16(5):304-7. PubMed ID: 3054452
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sequential methotrexate, 5-fluorouracil, and cisplatin in the treatment of recurrent squamous-cell carcinoma of the head and neck: failure of hypertonic saline to reduce the nephrotoxicity of cisplatin.
    Dimery IW; Legha SS
    J Clin Oncol; 1986 Nov; 4(11):1670-6. PubMed ID: 3095503
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant chemotherapy with cisplatin, methotrexate, bleomycin and vincristine (CABO) in patients with stage III and IV squamous cell carcinoma of the head and neck.
    Recloux P; Dodion PF; Andry G; Chantrain G; Dor P; Buyse M; Van Houtte P; Lemort M; Haesendonck P; Larsimont D
    Eur J Surg Oncol; 1989 Dec; 15(6):568-74. PubMed ID: 2480922
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methotrexate and 5-fluorouracil in sequence in squamous head and neck cancer.
    Pitman SW; Kowal CD; Bertino JR
    Semin Oncol; 1983 Jun; 10(2 Suppl 2):15-9. PubMed ID: 6346497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A randomized trial of adjuvant chemotherapy in head and neck cancer.
    Taylor SG; Applebaum E; Showel JL; Norusis M; Holinger LD; Hutchinson JC; Murthy AK; Caldarelli DD
    J Clin Oncol; 1985 May; 3(5):672-9. PubMed ID: 3889230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate and 5-fluorouracil in head and neck cancer.
    Ringborg U; Ewert G; Kinnman J; Lundquist PG; Strander H
    Semin Oncol; 1983 Jun; 10(2 Suppl 2):20-2. PubMed ID: 6603022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiation therapy with concomitant hydroxyurea and fluorouracil in stage II and III head and neck cancer.
    Haraf DJ; Kies M; Rademaker AW; Stenson K; Mittal B; Pelzer H; Wenig B; Witt ME; Sulzen L; Weichselbaum RR; Vokes EE
    J Clin Oncol; 1999 Feb; 17(2):638-44. PubMed ID: 10080609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Favorable long-term survival following induction chemotherapy with cisplatin, fluorouracil, and leucovorin and concomitant chemoradiotherapy for locally advanced head and neck cancer.
    Vokes EE; Weichselbaum RR; Mick R; McEvilly JM; Haraf DJ; Panje WR
    J Natl Cancer Inst; 1992 Jun; 84(11):877-82. PubMed ID: 1375657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy strategies in squamous cell carcinoma of the head and neck.
    Al-Sarraf M
    Crit Rev Oncol Hematol; 1984; 1(4):323-55. PubMed ID: 6085038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.